3B Blackbio Dx Limited
3B Blackbio Dx Limited is an Indian listed company in the Healthcare Services industry (Healthcare sector), traded under NSE: 3BBLACKBIO and BSE: 532067 (ISIN INE994E01018).
It has a market capitalisation of ₹1,141 crore, a last close of ₹1,331 on 2026-10-19.
Valuation: a price-to-earnings ratio of 19.47x, a price-to-book ratio of 3.52x, a dividend yield of 0.4%.
Profitability: return on equity of 19.8%, return on capital employed of 25.0%, an operating margin of 40.0%.
Growth: sales growth of 31.9% a year over three years, net profit growth of 37.2% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.01x.
| Metric | Value |
|---|---|
| Market capitalisation | 1,141 |
| Last close | ₹1,331 |
| P/E (TTM) | 19.47x |
| P/B | 3.52x |
| Dividend yield | 0.4% |
| ROE (FY) | 19.8% |
| ROCE (FY) | 25.0% |
| Operating margin (TTM) | 40.0% |
| Sales growth, 3-year CAGR | 31.9% |
| Profit growth, 3-year CAGR | 37.2% |
| Debt / equity | 0.01x |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means